Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

Market Cap	21.74B +8.8%
Revenue (ttm)	2.34B -10.5%
Net Income	2.40B +54.4%
EPS	2.04 +54.9%
Shares Out	1.17B
PE Ratio	9.08
Forward PE	n/a
Dividend	0.50 (2.81%)
Ex-Dividend Date	n/a

Volume	25,847,585
Average Volume	9,645,088
Open	17.91
Previous Close	17.79
Day's Range	17.91 - 18.71
52-Week Range	15.57 - 22.08
Beta	0.62
RSI	57.66
Earnings Date	Apr 18, 2026

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, re...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1957
• Employees: 5,461
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000623

Financial Performance

In 2025, SHE:000623's revenue was 2.34 billion, a decrease of -10.55% compared to the previous year's 2.61 billion. Earnings were 2.40 billion, an increase of 54.39%.